71 related articles for article (PubMed ID: 6117416)
1. The effect of trimepranol in the ischaemic focus in the dog.
Málek I; Kolc J; Mrhová O; Urbanová D
Cor Vasa; 1981; 23(4):299-309. PubMed ID: 6117416
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of Mercurascan after coronary artery ligation in the dog.
Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ischaemic heart disease with beta-adrenoblocking agents Trimepranol and Obsidan.
Gasilin VS; Grigoriants RA; Lupanov VP; Lobova NM
Cor Vasa; 1983; 25(1):10-6. PubMed ID: 6133699
[TBL] [Abstract][Full Text] [Related]
4. Dogs at high or low risk of ventricular fibrillation. An experimental study of acute myocardial ischaemia.
Fejfar Z; Vrána M
Cor Vasa; 1993; 35(2):64-70. PubMed ID: 8099001
[TBL] [Abstract][Full Text] [Related]
5. Prevention of ventricular fibrillation in experimental myocardial infarction.
Vrána M; Blazek Z; Fejfar Z; Netusil M; Trcka V
Cor Vasa; 1977; 19(3):243-5. PubMed ID: 923260
[TBL] [Abstract][Full Text] [Related]
6. [Effect of metipranolol on the cardiovascular system of the rabbit in vivo during spontaneous and paced heart rhythm].
Gersl V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1989; 32(4):371-87. PubMed ID: 2576986
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in myocardial basic fibroblast growth factor (FGF-2) activity following coronary artery ligation in the dog.
Cohen MV; Vernon J; Yaghdjian V; Hatcher VB
J Mol Cell Cardiol; 1994 May; 26(5):683-90. PubMed ID: 8072023
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacology of Metipranolol (trimepranol injection VUFB, Spofa tablets). The importance of clinical dosages].
Mayer O; Cepelák V; Vitous J
Vnitr Lek; 1981 Feb; 27(2):160-71. PubMed ID: 6110280
[No Abstract] [Full Text] [Related]
9. [Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
Smíd J; Hůla J; Kubín Z
Vnitr Lek; 1983 Apr; 29(4):325-31. PubMed ID: 6135276
[No Abstract] [Full Text] [Related]
10. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
[TBL] [Abstract][Full Text] [Related]
11. A minimally invasive model of myocardial infarction made by video-assisted thoracoscopic surgery.
Zhou XH; Li LD; Wu LM; Wang W; Han L; Yang J; Qiao HX; Zhou XF
Methods Find Exp Clin Pharmacol; 2007 May; 29(4):283-90. PubMed ID: 17609742
[TBL] [Abstract][Full Text] [Related]
12. [The effect of trimepranol on metabolism in the ischemic heart muscle].
Gvozdják J; Gvozdjáková A; Kucharská J; Bada V; Baranyai A; Drímal J
Vnitr Lek; 1985 Mar; 31(3):209-15. PubMed ID: 2863890
[No Abstract] [Full Text] [Related]
13. The early consequences of myocardial ischaemia and their modification.
Marshall RJ; Parratt JR
J Physiol (Paris); 1980; 76(7):699-715. PubMed ID: 6783744
[TBL] [Abstract][Full Text] [Related]
14. Effects of the lipolysis inhibiting agent beta-pyridylcarbinol (Ronicol) in acute myocardial ischaemia.
Fazekas T; Szekeres L
Acta Physiol Hung; 1989; 74(2):169-74. PubMed ID: 2603732
[TBL] [Abstract][Full Text] [Related]
15. [Effects of the beta-blocking agent atenolol on arrhythmias especially ventricular fibrillation and fibrillation threshold after acute experimental coronary artery occlusion (author's transl)].
Abendroth RR; Meesmann W; Stephan K; Schley G; Hübner H
Z Kardiol; 1977 Jul; 66(7):341-50. PubMed ID: 899134
[No Abstract] [Full Text] [Related]
16. Effect of mivazerol on myocardial lactate production, blood flow and electrocardiographic signs of ischaemia induced by coronary artery ligation in the anaesthetised dog.
Riemersma RA; Debeer LJ
Arzneimittelforschung; 1997 Jan; 47(1):10-3. PubMed ID: 9037436
[TBL] [Abstract][Full Text] [Related]
17. Acute coronary ligation in the dog induces time-dependent transitional changes in mitochondrial crista in the non-ischaemic ventricular myocardium.
McLachlan CS; Almsherqi ZA; Chua KS; Liew YY; Low CW; Deng Y
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):250-3. PubMed ID: 17250647
[TBL] [Abstract][Full Text] [Related]
18. [Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. I. Dynamic loading].
Smíd J; Jeschke J; Zeman V; Kubín Z
Vnitr Lek; 1983 Sep; 29(9):862-8. PubMed ID: 6138899
[No Abstract] [Full Text] [Related]
19. [Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. II. Isometric loading].
Smíd J; Kubín Z
Vnitr Lek; 1983 Sep; 29(9):869-75. PubMed ID: 6138900
[No Abstract] [Full Text] [Related]
20. Prevention of sudden coronary death.
Fejfar Z; Vrána M; Hess L; Vránová Z; Blazek Z
Czech Med; 1991; 14(1):22-34. PubMed ID: 1676965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
